Enter assignee name

EPO Patents = 4

Forward Citations = 2

Loading Chart...

7 inventors (with patents filed for the assignee):

Guenter Schmidt (5 out of 31 patents)

Nicolas Brieu (5 out of 11 patents)

Ansh Kapil (3 out of 5 patents)

4. Jan Martin Lesniak (2 out of 4 patents)

5. Tobias Wiestler (2 out of 2 patents)

6. Simon Lanzmich (2 out of 2 patents)

7. Moritz Widmaier (2 out of 2 patents)

8. Olivier Pauly (16 patents)

9. Gerd K Binnig (83 patents)

10. Günter Schmidt (0 patent)

11. Johannes Zimmermann (0 patent)

12. Günter Schmidt (0 patent)

6 patents: Sort by Forward Citations

1. 11977984 - Using a first stain to train a model to predict the region stained by a second stain (2024-05-07),

2. 11748981 - Deep learning method for predicting patient response to a therapy (2023-09-05),

3. 11651863 - Predicting prostate cancer recurrence using a prognostic model that combines immunohistochemical staining and gene expression profiling (2023-05-16),

4. 11593656 - Using a first stain to train a model to predict the region stained by a second stain (2023-02-28),

5. 11348231 - Deep learning method for predicting patient response to a therapy (2022-05-31),

6. 11030744 - Deep learning method for tumor cell scoring on cancer biopsies (2021-06-08),

AstraZeneca Computational Pathology GmbH is a subsidiary of AstraZeneca, a global biopharmaceutical company focused on developing innovative medicines for cardiovascular, renal, and metabolic diseases. The company specializes in using computational pathology to analyze tissue samples and develop personalized treatments for patients. With cutting-edge technology and a team of experts, AstraZeneca Computational Pathology GmbH is at the forefront of advancing precision medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

6 Patents

#268 in W-8000 Munich

#5,393 in Germany

Munich, Germany

Astrazeneca Computational Pathology Gmbh